<?xml version="1.0" ?>
<TABLE>
<ENTRY>
<ID>CHEBI:18297</ID>
<NAME>1D-myo-inositol 1-phosphate</NAME>
<DEFINITION>An inositol having myo- configuration substituted at position 1 by a phosphate group.</DEFINITION>
<STAR>3</STAR>
<SECONDARY_ID>CHEBI:12895</SECONDARY_ID>
<SECONDARY_ID>CHEBI:11354</SECONDARY_ID>
<SECONDARY_ID>CHEBI:43432</SECONDARY_ID>
<SECONDARY_ID>CHEBI:818</SECONDARY_ID>
<SECONDARY_ID>CHEBI:11220</SECONDARY_ID>
<SECONDARY_ID>CHEBI:12828</SECONDARY_ID>
<SECONDARY_ID>CHEBI:19207</SECONDARY_ID>
<SYNONYM>Myoinositol 1-phosphate</SYNONYM>
<SYNONYM>Ins1P</SYNONYM>
<SYNONYM>Ins(1)P</SYNONYM>
<SYNONYM>Inositol 1-phosphate</SYNONYM>
<SYNONYM>Inositol 1-phosphate</SYNONYM>
<SYNONYM>I1P</SYNONYM>
<SYNONYM>D-myo-Inositol 1-phosphate</SYNONYM>
<SYNONYM>1D-myo-Inositol 1-phosphate</SYNONYM>
<SYNONYM>1D-myo-Inositol 1-monophosphate</SYNONYM>
<IUPAC_NAME>(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl dihydrogen phosphate</IUPAC_NAME>
<FORMULA>C6H13O9P</FORMULA>
<MASS>260.13578</MASS>
<MONOISOTOPIC_MASS>260.030</MONOISOTOPIC_MASS>
<CHARGE>0</CHARGE>
<SMILES>O[C@H]1[C@H](O)[C@@H](O)[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O</SMILES>
<INCHI>InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/t1-,2-,3+,4-,5-,6-/m1/s1</INCHI>
<INCHIKEY>INAPMGSXUVUWAF-UOTPTPDRSA-N</INCHIKEY>
<BEILSTEIN_REGISTRY_NUMBER>2056776</BEILSTEIN_REGISTRY_NUMBER>
<CAS_REGISTRY_NUMBER>15421-51-9</CAS_REGISTRY_NUMBER>
<REAXYS_REGISTRY_NUMBER>2056776</REAXYS_REGISTRY_NUMBER>
<CHEMIDPLUS>15421-51-9</CHEMIDPLUS>
<DRUGBANK_ACCESSION>DB03542</DRUGBANK_ACCESSION>
<HMDB_ACCESSION>HMDB0000213</HMDB_ACCESSION>
<KEGG_COMPOUND_ACCESSION>C01177</KEGG_COMPOUND_ACCESSION>
<KNAPSACK_ACCESSION>C00007483</KNAPSACK_ACCESSION>
<METACYC_ACCESSION>D-MYO-INOSITOL-1-MONOPHOSPHATE</METACYC_ACCESSION>
<PDBECHEM_ACCESSION>IPD</PDBECHEM_ACCESSION>
<PUBMED_CITATION>17439666</PUBMED_CITATION>
</ENTRY>
</TABLE>
